Back to Search
Start Over
Preliminary Study of the Relationship between Osteopontin and Relapsed Hodgkin's Lymphoma.
- Source :
- Biomedicines; Jan2024, Vol. 12 Issue 1, p31, 19p
- Publication Year :
- 2024
-
Abstract
- The primary objective of this study was to investigate the potential role of tissue osteopontin, also known as secreted phosphoprotein 1 (SPP1), as a contributing factor to an unfavorable prognosis in classical Hodgkin's lymphoma (HL) patients who received the same treatment protocol. The study involved 44 patients aged 4–22 years, with a median follow-up period of 3 years. Patients with higher levels of SPP1 were associated with tissue necrosis and inflammation, and there was a trend toward a poorer prognosis in this group. Before therapy, we found a correlation between positron emission tomography (PET) scans and logarithmic SPP1 levels (p = 0.035). However, the addition of SPP1 levels did not significantly enhance the predictive capacity of PET scans for recurrence or progression. Elevated SPP levels were associated with tissue mRNA counts of chemotactic and inflammatory chemokines, as well as specific monocyte/dendritic cell subtypes, defined by IL-17RB, PLAUR, CXCL8, CD1A, CCL13, TREM1, and CCL24 markers. These findings contribute to a better understanding of the potential factors influencing the prognosis of HL patients and the potential role of SPP1 in the disease. While the predictive accuracy of PET scans did not substantially improve during the study, the results underscore the complexity of HL and highlight the relationships between SPP1 and other factors in the context of HL relapse. [ABSTRACT FROM AUTHOR]
- Subjects :
- HODGKIN'S disease
OSTEOPONTIN
POSITRON emission tomography
DENDRITIC cells
Subjects
Details
- Language :
- English
- ISSN :
- 22279059
- Volume :
- 12
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- Biomedicines
- Publication Type :
- Academic Journal
- Accession number :
- 175047609
- Full Text :
- https://doi.org/10.3390/biomedicines12010031